UCP2-Mimetic Compounds Induce Mitophagy to Reduce Oxidative Stress
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Impaired mitophagy leads to excessive ROS formation, contributing to degenerative diseases associated with aging, particularly in non-renewable tissues like neurons and heart muscle cells, where mitochondrial dysfunction plays a key role in conditions such as Parkinson's disease and oxidative stress.
Innovation Solution
A compound with a specific general formula (R1—X1-L-X2—R2) is developed to enhance mitophagy, promoting the removal of damaged mitochondria and reducing oxidative injury, thereby protecting cells from paraquat-induced damage and facilitating the treatment of diseases related to impaired mitophagy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If mitophagy is impaired with aging, then damaged mitochondria accumulate, but cellular function deteriorates and oxidative stress increases
Solution Approach 1:
The patent converts the harmful accumulation of damaged mitochondria into a beneficial process by inducing mitophagy. The compound UCP2-mimetics trigger the selective degradation of damaged mitochondria through autophagy, transforming the harmful oxidative stress condition into a protective mechanism that removes damaged organelles and reduces ROS production.
Solution Approach 2:
The patent introduces UCP2-mimetics as an intermediary substance that mediates between the accumulated damaged mitochondria and the cellular quality control system. These compounds activate mitophagy pathways, serving as a bridge that enables the cell to recognize and eliminate damaged mitochondria without direct cellular intervention.
2Object-generated harmful factors
If mitophagy is enhanced to remove damaged mitochondria, then oxidative stress is reduced, but cellular energy production may be affected
Solution Approach 1:
The patent changes the functional parameters of mitochondria by inducing selective degradation of damaged ones while preserving healthy ones. By modulating the mitophagy process through UCP2-mimetics, the system maintains energy production from functional mitochondria while eliminating those that produce excessive ROS, thus optimizing the energy/oxidative stress balance.
Solution Approach 2:
The patent applies local quality control by selectively targeting damaged mitochondria for degradation while sparing healthy ones. The mitophagy process is spatially and functionally selective, removing only those mitochondria that have exceeded functional thresholds and are producing harmful ROS, thereby preserving overall cellular energy production.
3Reliability
If compounds are designed to induce mitophagy, then protection against paraquat-induced damage is achieved, but molecular complexity increases
Solution Approach 1:
The patent uses UCP2-mimetics that copy the functional properties of endogenous UCP2 protein without requiring the full complexity of the natural protein structure. These simplified molecular copies retain the key ability to induce mitophagy and protect against oxidative stress while being chemically tractable and suitable for therapeutic development.
Data Source
AI summary
The invention provides compounds and uses thereof in the treatment and prevention of diseases and conditions associate with or aggravated by impaired mitophagy or oxidative stress, and methods of their preparation.